Strides Pharma Reports Net Profit Of ₹10.44 Cr In Q4F

Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.

Related Keywords

Aditya Kumar , Badree Komandur , Surabhi Loshali , Barun Kumar , Strides Pharma Science Ltd On , Business Development , Strides Pharma Science Ltd , Executive Chairperson , Managing Director Arun Kumar , Executive Director Finance , Strides Pharma Science , Vice President , Executive Director , Avikesh Kumar , End Markets , Investor Relations Officer , Senior Vice President , Pharma Founder ,